Compared to GPRC5A wild-type cells, GPRC5A knockout cells have higher levels of activated-STAT3 and STAT3-regulated anti-apoptotic genes, independent of the presence of exogenous epidermal growth factor (EGF), resulting in enhancement of tumor progression [66, 67]. This evidence concerns the gene EGF and neoplasm.